The Global Humanized Mice Model Market is set for growth driven by technological advancements in genetic engineering and ...

Orna Therapeutics (Orna), a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced new preclinical data supporting the Company's ...

Vascarta Inc., is pleased to share results from a new study led by researchers at the U.S. Food and Drug Administration's ...

The result was IgE-K: a conjugate vaccine that teaches the immune system to recognize and neutralize IgE. When injected into ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

An international team led by two Université de Montréal researchers has unveiled how a molecule capable of opening the "shell ...

Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful ...

Adding spironolactone to HIV treatment shows promise in accelerating viral decay and reducing inflammation linked to chronic ...

Researchers have developed a molecule called SU212 that could revolutionize treatment for triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease.

Addressing Current Limitations in Spatial OmicsExisting tools for spatial proteomics often have constraints. Many are not equipped to predict multiple ...